19.98
0.00%
+0.00
After Hours:
19.98
Overview
News
Price History
Option Chain
Why PHG Down?
Discussions
Forecast
Stock Split
Dividend History
Koninklijke Philips N.V. ADR stock is currently priced at $19.98, with a 24-hour trading volume of 533.67K.
It has seen a +0.00% increased in the last 24 hours and a -3.94% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $20.02 pivot point. If it approaches the $19.89 support level, significant changes may occur.
Koninklijke Philips N.V. ADR Stock (PHG) Financials Data
Koninklijke Philips N.V. ADR (PHG) Revenue 2024
PHG reported a revenue (TTM) of $19.67 billion for the quarter ending December 31, 2023, a +5.00% rise year-over-year.
Koninklijke Philips N.V. ADR (PHG) Net Income 2024
PHG net income (TTM) was -$497.91 million for the quarter ending December 31, 2023, a +69.64% increase year-over-year.
Koninklijke Philips N.V. ADR (PHG) Earnings per Share 2024
PHG earnings per share (TTM) was -$0.5428 for the quarter ending December 31, 2023, a +69.37% growth year-over-year.
Koninklijke Philips N.V. ADR Stock (PHG) Latest News
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
Zacks Investment Research
Wall Street Breakfast Podcast: Intel Unveils New AI Chip, Setting Up Race With Nvidia
Seeking Alpha
Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward
GlobeNewswire Inc.
Philips (PHG) Boosts Patient Monitoring With smartQare Deal
Zacks Investment Research
Philips convenes the Annual General Meeting of Shareholders 2024
GlobeNewswire Inc.
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
GlobeNewswire Inc.
About Koninklijke Philips N.V. ADR
Koninklijke Philips N.V. operates as a health technology company worldwide. The company offers mother and child care, and oral healthcare products; male grooming and beauty products; kitchen appliance, coffee, air, garment care, and floor care products; and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. In addition, the company offers interventional X-ray systems, and imaging and therapy devices for the treatment of coronary artery and peripheral vascular disease; imaging products that focus on diagnosis, treatment planning, and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; and proprietary software to enable diagnostics and intervention. Further, it provides enterprise wide patient monitoring solutions; patient analytics and monitoring, and clinical decision support systems; therapeutic care products; patient monitoring and therapeutic care consumables; and customer services. Additionally, the company offers healthcare information technology (IT), clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology departments; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. It also provides digital platforms that connect consumers, patients, and healthcare providers in a cloud-based connected health ecosystem of devices, apps, and tools. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Cap:
|
Volume (24h):